203 related articles for article (PubMed ID: 2026611)
1. Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides.
Munch-Petersen B; Cloos L; Tyrsted G; Eriksson S
J Biol Chem; 1991 May; 266(14):9032-8. PubMed ID: 2026611
[TBL] [Abstract][Full Text] [Related]
2. Substrate/inhibitor properties of human deoxycytidine kinase (dCK) and thymidine kinases (TK1 and TK2) towards the sugar moiety of nucleosides, including O'-alkyl analogues.
Kierdaszuk B; Krawiec K; Kazimierczuk Z; Jacobsson U; Johansson NG; Munch-Petersen B; Eriksson S; Shugar D
Nucleosides Nucleotides; 1999 Aug; 18(8):1883-903. PubMed ID: 10478487
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in thymidine kinase 2 (TK2) inhibitors and new perspectives for potential applications.
Priego EM; Karlsson A; Gago F; Camarasa MJ; Balzarini J; Pérez-Pérez MJ
Curr Pharm Des; 2012; 18(20):2981-94. PubMed ID: 22571666
[TBL] [Abstract][Full Text] [Related]
4. The kinetic effects on thymidine kinase 2 by enzyme-bound dTTP may explain the mitochondrial side effects of antiviral thymidine analogs.
Wang L; Sun R; Eriksson S
Antimicrob Agents Chemother; 2011 Jun; 55(6):2552-8. PubMed ID: 21444706
[TBL] [Abstract][Full Text] [Related]
5. Substrate/inhibitor specificities of human deoxycytidine kinase (dCK) and thymidine kinases (TK1 and TK2).
Kierdaszuk B; Krawiec K; Kazimierczuk Z; Jacobsson U; Johansson NG; Munch-Petersen B; Eriksson S; Shugar D
Adv Exp Med Biol; 1998; 431():623-7. PubMed ID: 9598140
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of mitochondrial factors modulating thymidine kinase 2 activity.
Sun R; Eriksson S; Wang L
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):382-5. PubMed ID: 20544523
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs.
Eriksson S; Kierdaszuk B; Munch-Petersen B; Oberg B; Johansson NG
Biochem Biophys Res Commun; 1991 Apr; 176(2):586-92. PubMed ID: 2025274
[TBL] [Abstract][Full Text] [Related]
8. Human thymidine kinase 2: molecular cloning and characterisation of the enzyme activity with antiviral and cytostatic nucleoside substrates.
Wang L; Munch-Petersen B; Herrström Sjöberg A; Hellman U; Bergman T; Jörnvall H; Eriksson S
FEBS Lett; 1999 Jan; 443(2):170-4. PubMed ID: 9989599
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability and cytosolic kinases modulate response to deoxynucleoside therapy in TK2 deficiency.
Lopez-Gomez C; Hewan H; Sierra C; Akman HO; Sanchez-Quintero MJ; Juanola-Falgarona M; Tadesse S; Tanji K; Konofagou EE; Hirano M
EBioMedicine; 2019 Aug; 46():356-367. PubMed ID: 31383553
[TBL] [Abstract][Full Text] [Related]
10. Anti-retrovirus activity of 3'-fluoro- and 3'-azido-substituted pyrimidine 2',3'-dideoxynucleoside analogues.
Balzarini J; Baba M; Pauwels R; Herdewijn P; De Clerq E
Biochem Pharmacol; 1988 Jul; 37(14):2847-56. PubMed ID: 2840080
[TBL] [Abstract][Full Text] [Related]
11. 5-Bromovinyl 2'-deoxyuridine phosphorylation by mitochondrial and cytosolic thymidine kinase (TK2 and TK1) and its use in selective measurement of TK2 activity in crude extracts.
Wang L; Eriksson S
Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):858-62. PubMed ID: 18600552
[TBL] [Abstract][Full Text] [Related]
12. 3'-Azido-2',3'-dideoxythymidine induced deficiency of thymidine kinases 1, 2 and deoxycytidine kinase in H9 T-lymphoid cells.
Gröschel B; Kaufmann A; Höver G; Cinatl J; Doerr HW; Noordhuis P; Loves WJ; Peters GJ; Cinatl J
Biochem Pharmacol; 2002 Jul; 64(2):239-46. PubMed ID: 12123744
[TBL] [Abstract][Full Text] [Related]
13. Bromovinyl-deoxyuridine: A selective substrate for mitochondrial thymidine kinase in cell extracts.
Franzolin E; Rampazzo C; Pérez-Pérez MJ; Hernández AI; Balzarini J; Bianchi V
Biochem Biophys Res Commun; 2006 May; 344(1):30-6. PubMed ID: 16630572
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of the anti-hepatitis B nucleoside analog 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil (FIAU) by human cytosolic and mitochondrial thymidine kinase and implications for cytotoxicity.
Wang J; Eriksson S
Antimicrob Agents Chemother; 1996 Jun; 40(6):1555-7. PubMed ID: 8726039
[TBL] [Abstract][Full Text] [Related]
15. Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues.
Arnér ES; Spasokoukotskaja T; Eriksson S
Biochem Biophys Res Commun; 1992 Oct; 188(2):712-8. PubMed ID: 1359886
[TBL] [Abstract][Full Text] [Related]
16. Expression of human mitochondrial thymidine kinase in Escherichia coli: correlation between the enzymatic activity of pyrimidine nucleoside analogues and their inhibitory effect on bacterial growth.
Wang J; Su C; Neuhard J; Eriksson S
Biochem Pharmacol; 2000 Jun; 59(12):1583-8. PubMed ID: 10799656
[TBL] [Abstract][Full Text] [Related]
17. Substrate specificity of feline and canine herpesvirus thymidine kinase.
Solaroli N; Johansson M; Persoons L; Balzarini J; Karlsson A
Antiviral Res; 2008 Aug; 79(2):128-32. PubMed ID: 18455811
[TBL] [Abstract][Full Text] [Related]
18. Differential patterns of intracellular metabolism of 2',3'-didehydro-2',3'-dideoxythymidine and 3'-azido-2',3'-dideoxythymidine, two potent anti-human immunodeficiency virus compounds.
Balzarini J; Herdewijn P; De Clercq E
J Biol Chem; 1989 Apr; 264(11):6127-33. PubMed ID: 2539371
[TBL] [Abstract][Full Text] [Related]
19. Deoxynucleoside phosphorylating enzymes in monkey and human tissues show great similarities, while mouse deoxycytidine kinase has a different substrate specificity.
Habteyesus A; Nordenskjöld A; Bohman C; Eriksson S
Biochem Pharmacol; 1991 Oct; 42(9):1829-36. PubMed ID: 1657002
[TBL] [Abstract][Full Text] [Related]
20. Stereoisomeric selectivity of human deoxyribonucleoside kinases.
Wang J; Choudhury D; Chattopadhyaya J; Eriksson S
Biochemistry; 1999 Dec; 38(51):16993-9. PubMed ID: 10606535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
